SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-21-040874
Filing Date
2021-02-12
Accepted
2021-02-12 12:59:59
Documents
3
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND V GP MANAGER, LTDOMEGA FUND V GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d122985dsc13ga.htm SC 13G/A 134534
2 EX-99.1 d122985dex991.htm EX-99.1 7099
3 EX-99.2 d122985dex992.htm EX-99.2 10519
  Complete submission text file 0001193125-21-040874.txt   153763
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund V, L.P. (Filed by) CIK: 0001641354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Subject) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91334 | Film No.: 21625026
SIC: 2834 Pharmaceutical Preparations